Mixed Hyperlipidemia

1

Review clinical trials related to Mixed Hyperlipidemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia

This is a randomized, double-blind, placebo-parallel, multicenter phase II clinical trial to evaluate the efficacy and safety of SYH2070 injection in participants with mixed hyperlipidemia.

Participants needed: 240
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.Updated: Jul 22, 2026Locations: 1
Eligibility criteria

Age ≥ 18 years old, no gender limitation; [+6]

Genetic diagnosis or clinical diagnosis indicates homozygous familial hyperchole... [+25]